カリポリド (HOE642),選択的なNa+-H+交換阻害剤は,ミトコンドリア死亡経路を阻害する

Yasushi Teshima¹, Masaharu Akao, Steven P Jones

¹Institute of Molecular Cardiobiology, Johns Hopkins University, 720 Rutland Ave, 844 Ross Building, Baltimore, Md 21205, USA.

Circulation

|October 22, 2003

まとめ

カリポリドは,Na+-H+交換器阻害剤であり,イオンバランスとミトコンドリア機能を維持することによって,酸化ストレスから心臓細胞を保護します. これは,心不全-再流血損傷中の細胞死を減少させます.

科学分野:

心血管科学の研究について
細胞生物学細胞生物学
薬理学薬理学とは

背景:

心臓のイシュケミア再注血による損傷には,Na+-H+交換器が関与しています.
Na+-H+交換器の阻害は心臓保護効果を示しているが,そのメカニズムは不明である.

研究の目的:

カーディオミオサイトにおける酸化ストレスに対するカリポリドの保護機構を調査する.
カリポライドが細胞内イオンホメオスタシスとミトコンドリア機能に及ぼす影響について解明する.

主な方法:

培養された新生児ラット心筋細胞は,酸化ストレス (H2O2) に晒されている.
評価された細胞死マーカー (TUNEL,カスパース3分裂,フォスファディチルセリンの曝露,プロピジウムヨウ酸化物の吸収).
細胞内Na+,Ca2+,およびミトコンドリアのCa2+レベルを測定し,ミトコンドリア膜の潜在力を評価した.

主要な成果:

カリポライドは,心筋細胞死亡マーカーを著しく減少させた.
カリポライドは,H2O2誘発の細胞内Na+とCa2+の蓄積を抑制した.
カリポライドは,ミトコンドリアのCa2+過負荷とミトコンドリア膜ポテンシャルの喪失を防止しました.

結論:

カリポリドは,心筋細胞を酸化物質による死から保護する.
細胞内イオンホメオスタシスの保存は,重要なメカニズムです.
ミトコンドリアの完全性の維持は,心臓の保護に貢献します.

さらに関連する動画

08:25

Voltage and Calcium Dual Channel Optical Mapping of Cultured HL-1 Atrial Myocyte Monolayer

Published on: March 23, 2015

14:39

Cholinergic Ligand–dependent Modulation of Oxidative Phosphorylation Coupling in Digitonin-permeabilized BE(2)-C Neuroblastoma Cells

Published on: April 28, 2026

関連する概念動画

01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...

01:26

Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin

Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...

01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...

01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...

01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...

01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...

関連する実験動画